Vieito , M., González Rodríguez, M., Valdivia Bustamante, A., Carles, J., & Suárez, C. (2023). Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel–Lindau-Disease-Associated Tumors.
Citación estilo ChicagoVieito , Maria, Macarena González Rodríguez, Augusto Valdivia Bustamante, Joan Carles, y Cristina Suárez. Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel–Lindau-Disease-Associated Tumors. 2023.
Cita MLAVieito , Maria, et al. Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel–Lindau-Disease-Associated Tumors. 2023.
Precaución: Estas citas no son 100% exactas.